| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (oxacillin-resistant) |
0.12 |
2 |
≤0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin)  |
462 |
| Staphylococcus aureus (oxacillin-resistant) |
0.125 |
0.25 |
0.06 － 0.125 |
PD 0305970 |
225 |
| Staphylococcus aureus (oxacillin-resistant) |
0.25 |
0.25 |
≤0.06 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Staphylococcus aureus (oxacillin-resistant) |
0.25 |
0.25 |
0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
476 |
| Staphylococcus aureus (oxacillin-resistant) |
0.25 |
0.5 |
0.125 － 1 |
PD 0326448 |
225 |
| Staphylococcus aureus (oxacillin-resistant) |
0.25 |
0.5 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
39 |
| Staphylococcus aureus (oxacillin-resistant) |
0.25 |
2 |
0.12 － 16 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
476 |
| Staphylococcus aureus (oxacillin-resistant) |
0.25 |
30 |
≤0.12 － >30 |
Gentamicin (Gentamycin, Garamycin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
0.5 |
0.12 － 2 |
Quinupristin/Dalfopristin (Synercid) |
265 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
0.5 |
0.25 － 1 |
Quinupristin/Dalfopristin (Synercid) |
446 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
0.5 |
0.25 － 1 |
Quinupristin/Dalfopristin (Synercid) |
496 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
1 |
0.25 － 1 |
Tigecycline (GAR-936, Tigacyl) |
476 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
1 |
≤0.25 － 2 |
Tiamulin (Tiamuline, Tiamutilin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
1 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
39 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
2 |
0.25 － 2 |
LBM415 (NVP-PDF-713, VIC-10495) |
265 |
| Staphylococcus aureus (oxacillin-resistant) |
>0.5 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
462 |
| Staphylococcus aureus (oxacillin-resistant) |
>0.5 |
>4 |
≤0.5 － >4 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
265 |
| Staphylococcus aureus (oxacillin-resistant) |
>0.5 |
>8 |
≤0.06 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
462 |
| Staphylococcus aureus (oxacillin-resistant) |
1 |
2 |
0.12 － 4 |
Oritavancin (LY333328) |
43 |
| Staphylococcus aureus (oxacillin-resistant) |
1 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
43 |
| Staphylococcus aureus (oxacillin-resistant) |
1 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
265 |
| Staphylococcus aureus (oxacillin-resistant) |
1 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
39 |
| Staphylococcus aureus (oxacillin-resistant) |
1 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
126 |
| Staphylococcus aureus (oxacillin-resistant) |
>1 |
>4 |
≤0.03 － >4 |
Trovafloxacin (Trovan) |
462 |
| Staphylococcus aureus (oxacillin-resistant) |
2 |
2 |
0.03 － 4 |
Garenoxacin (T-3811, BMS-284756) |
225 |
| Staphylococcus aureus (oxacillin-resistant) |
>2 |
>2 |
0.12 － >2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
>2 |
>2 |
≤0.25 － >2 |
Clindamycin (Cleocin) |
462 |
| Staphylococcus aureus (oxacillin-resistant) |
2 |
2 |
0.25 － 2 |
Teicoplanin (Targocid) |
43 |